Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Estrogen, progestogens and cardiovascular risk.

M L Stefanick1

  • 1Stanford Center for Research in Disease Prevention, Stanford University School of Medicine, 730 Welch Road, #B, MC-5736, Stanford, CA 94304-1583, USA.

The Journal of Reproductive Medicine
|June 8, 2001
PubMed
Summary

Hormone replacement therapy (HRT) favorably impacts HDL cholesterol and reduces LDL cholesterol and fibrinogen. However, some HRT regimens may increase glucose levels, while blood pressure remains unaffected.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reproductive history and osteoarthritis in the Women's Health Initiative.

Scandinavian journal of rheumatology·2020
Same author

Metabolic phenotypes of obesity: frequency, correlates and change over time in a cohort of postmenopausal women.

International journal of obesity (2005)·2016
Same author

Association of nonmelanoma skin cancer with second noncutaneous malignancy in the Women's Health Initiative.

The British journal of dermatology·2016
Same author

Associations of total and free 25OHD and 1,25(OH)2D with serum markers of inflammation in older men.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2016
Same author

Active and passive smoking in relation to lung cancer incidence in the Women's Health Initiative Observational Study prospective cohort.

Annals of oncology : official journal of the European Society for Medical Oncology·2014
Same author

Alcohol consumption and body weight change in postmenopausal women: results from the Women's Health Initiative.

International journal of obesity (2005)·2012

Area of Science:

  • Endocrinology
  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Hormone replacement therapy (HRT) is widely used by postmenopausal women.
  • Cardiovascular risk factors are a significant concern for this population.
  • Understanding HRT's effects on cardiovascular health is crucial.

Purpose of the Study:

  • To review the impact of HRT on cardiovascular risk factors.
  • To analyze lipid and nonlipid parameters in postmenopausal women undergoing HRT.
  • To evaluate cardiovascular risks associated with oral contraceptives.

Main Methods:

  • Review of recent studies on HRT and cardiovascular risk.
  • Analysis of data from the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial.
  • Examination of lipid profiles (HDL, LDL) and nonlipid parameters (fibrinogen, glucose, blood pressure, weight).

Main Results:

  • HRT, particularly conjugated equine estrogen (CEE) with micronized progesterone (MP), increased HDL cholesterol.
  • Low-density lipoprotein cholesterol decreased by 10-15% in all active HRT groups.
  • Fibrinogen levels were reduced with HRT; glucose levels showed mixed results, and blood pressure was unaffected. Weight gain was lower with HRT.
  • Current oral contraceptives have fewer adverse lipid effects than older formulations.

Conclusions:

  • HRT demonstrates beneficial effects on key cardiovascular risk factors, including lipids and fibrinogen.
  • Specific HRT formulations influence glucose metabolism differently.
  • HRT may be associated with reduced weight gain compared to placebo.
  • Modern oral contraceptives present a lower cardiovascular risk profile compared to previous generations.

Related Experiment Videos